Cardiotoxicity of radiation therapy in esophageal cancer

被引：23
作者：
Vosmik, Milan [1 ]
Hodek, Miroslav [1 ]
Buka, David [1 ]
Sykorova, Petra [1 ]
Grepl, Jakub [1 ]
Paluska, Petr [1 ]
Paulikova, Simona [1 ]
Sirak, Igor [1 ]
机构：
[1] Univ Hosp Hradec Kralove, Dept Oncol & Radiotherapy, Hradec Kralove, Czech Republic
来源：
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY | 2020年 / 25卷 / 03期
关键词：
Esophageal cancer; Radiation therapy; Cardiac toxicity; SQUAMOUS-CELL CARCINOMA; CLINICAL TARGET VOLUME; MODULATED ARC THERAPY; PROTON-BEAM THERAPY; DEFINITIVE CHEMORADIOTHERAPY; PERICARDIAL-EFFUSION; CARDIAC TOXICITY; HEART-DISEASE; PREOPERATIVE CHEMORADIOTHERAPY; TIME TRENDS;
D O I：
10.1016/j.rpor.2020.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
With a development of radiotherapeutic techniques, availability of radiotherapy data on cardiotoxicity, and slowly improving esophageal cancer outcomes, an increasing emphasis is placed on the heart protection in radiation treated esophageal cancer patients. Radiation induced heart complications encompass mainly pericardial disease, cardiomyopathy, coronary artery atherosclerosis, valvular heart disease, and arrhythmias. The most frequent toxicity is pericardial effusion which is usually asymptomatic in the majority of patients. The use of modern radiotherapy techniques is expected to reduce the risk of cardiotoxicity, although this expectation has to be confirmed by clinical data. (C) 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：318 / 322
页数：5
相关论文
共 55 条
  • [1] [Anonymous], 1993, J ICRU
  • [2] [Anonymous], 2019, ES ES JUNCT CANC VER
  • [3] Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?
    Beukema, Jannet C.
    van Luijk, Peter
    Widder, Joachim
    Langendijk, Johannes A.
    Muijs, Christina T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 114 (01) : 85 - 90
  • [4] Helical tomotherapy for radiotherapy in esophageal cancer: A preferred plan with better conformal target coverage and more homogeneous dose distribution
    Chen, Yi-Jen
    Liu, An
    Han, Chunhui
    Tsai, Peter T.
    Schultheiss, Timothy E.
    Pezner, Richard D.
    Vora, Nilesh
    Lim, Dean
    Shibata, Stephen
    Kernstine, Kemp H.
    Wong, Jeffrey Y. C.
    [J]. MEDICAL DOSIMETRY, 2007, 32 (03) : 166 - 171
  • [5] Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience
    Choi, Kyu Hye
    Kim, Jina
    Lee, Sea-Won
    Kang, Young-nam
    Jang, HongSeok
    [J]. RADIATION ONCOLOGY JOURNAL, 2018, 36 (01): : 63 - 70
  • [6] Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
    Conroy, Thierry
    Galais, Marie-Pierre
    Raoul, Jean-Luc
    Bouche, Olivier
    Gourgou-Bourgade, Sophie
    Douillard, Jean-Yves
    Etienne, Pierre-Luc
    Boige, Valerie
    Martel-Lafay, Isabelle
    Michel, Pierre
    Llacer-Moscardo, Carmen
    Francois, Eric
    Crehange, Gilles
    Ben Abdelghani, Meher
    Juzyna, Beata
    Bedenne, Laurent
    Adenis, Antoine
    [J]. LANCET ONCOLOGY, 2014, 15 (03) : 305 - 314
  • [7] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [8] Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
    Darby, Sarah C.
    Ewertz, Marianne
    McGale, Paul
    Bennet, Anna M.
    Blom-Goldman, Ulla
    Bronnum, Dorthe
    Correa, Candace
    Cutter, David
    Gagliardi, Giovanna
    Gigante, Bruna
    Jensen, Maj-Britt
    Nisbet, Andrew
    Peto, Richard
    Rahimi, Kazem
    Taylor, Carolyn
    Hall, Per
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) : 987 - 998
  • [9] Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases
    Dong, Yuanli
    Guan, Hui
    Huang, Wei
    Zhang, Zicheng
    Zhao, Dongbo
    Liu, Yang
    Zhou, Tao
    Li, Baosheng
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (12) : 2313 - 2320
  • [10] Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU More than 20 years' experience at a single institution
    Fakhrian, Khashayar
    Ordu, Arif Deniz
    Lordick, Florian
    Theisen, Joerg
    Haller, Bernhard
    Omrcen, Tomislav
    Molls, Michael
    Nieder, Carsten
    Geinitz, Hans
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (12) : 1133 - 1140
123456